Target intelligence / Profile preview

High-mannose N-linked glycan (HMG)

Target
HMG
Molecular classification
Glycan, Post-translational modification
01

Overview

High-mannose N-linked glycans are a type of carbohydrate modification found extensively on the surface glycoproteins of enveloped viruses, including HIV-1, SARS-CoV-2, and Ebola. These glycans are characterized by a core of N-acetylglucosamine and multiple mannose residues, often forming a dense glycan shield that masks underlying protein epitopes from the host immune system (Watanabe et al., 2020, Nature Communications). In many viral pathogens, the high density of these glycans prevents host enzymes from processing them into complex forms, leaving a high-mannose patch that is distinct from the more processed glycans found on most host proteins (Doores, 2015, Carbohydrate Research). This unique signature makes them an attractive target for broadly neutralizing antibodies (bNAbs) and lectins, which can bind these clusters to neutralize the virus or trigger immune responses (Walker et al., 2011, Nature). Therapeutic development focuses on using these glycans as targets for vaccines or as docking sites for entry inhibitors to prevent infection and spread. Furthermore, the presence of these glycans is critical for proper protein folding and stability of the viral envelope spikes. Because they are less prevalent on mature human proteins, they offer a degree of selectivity for antiviral intervention.

Other names
Oligomannose glycanHigh-mannose patchMan5-9GlcNAc2Viral glycan shieldHigh-mannose N-linked glycans on enveloped virus glycoproteins
02

Mechanism of action

Binding to high-mannose clusters on viral glycoproteins to sterically hinder receptor binding or facilitate immune-mediated clearance.

03

Biological functions

Viral entryImmune evasionProtein foldingHost-pathogen interaction
04

Disease associations

Infection
05

Safety considerations

Potential cross-reactivity with host high-mannose glycansImmunogenicity of non-human lectinsRapid renal clearance of small carbohydrate-binding agents
06

Interacting drugs

PGT121

6 more in the full profile.

07

Biomarkers

Viral glycan profilingSerum glycan-binding antibody titers

Beyond the preview

Go deeper on High-mannose N-linked glycan (HMG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High-mannose N-linked glycan (HMG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call